2025-06-05T13:23:33+00:00 2024-12-31 350921680 CROWE LLP 225 West Wacker Drive Suite 2600 Chicago IL 606061224 990 2024-01-01 273941186 The End Fund Inc ENDF 6466909775 2 Park Avenue 28th Floor New York NY 10016 HANNAH CHANG Senior Director Finance/Admin 6466909775 2025-06-05 true MALLORY FAIRLESS P01321579 3128997000 2025-06-05 2024 2025-03-06 01:10:19Z DR SOLOMON ZEWDU (beg 1125) 2 Park Avenue 28th Floor New York NY 10016 62698882 false X WWW.END.ORG X 2010 DE The END Fund's mission is to control and eliminate six neglected tropical diseases: river blindness, lymphatic filariasis, trachoma, schistosomiasis, intestinal worms, and visceral leishmaniasis. 6 6 44 8 0 55663487 61399678 0 690371 928656 38500 344548 56392358 62672882 45424627 50887450 0 11292590 13046152 0 4628781 7325696 10247955 64042913 74181557 -7650555 -11508675 50403877 38929869 2684934 2786090 47718943 36143779 The END Fund's mission is to control and eliminate six neglected tropical diseases: river blindness, lymphatic filariasis, trachoma, schistosomiasis, intestinal worms, and visceral leishmaniasis. false false 66987920 50887450 The END Fund is a leading philanthropic community dedicated to ending six neglected tropical diseases that impact 1.65 billion people globally: intestinal worms, schistosomiasis, lymphatic filariasis, river blindness, trachoma, and visceral leishmaniasis. The END Fund efficiently puts private capital to work, advocating for neglected tropical disease programs that are innovative, integrated and cost-effective. We facilitate strong partnerships with the private sector, government partners, and local programmatic partners to collaboratively support national disease programs. This is done through a proven implementation model that is tailored to meet the needs of individual countries. The END Fund was established as a new model, the first of its kind in the neglected tropical disease field: a philanthropic fund that increases resources, coordination, and collaboration toward the goal of ending neglected tropical diseases, thereby reducing the physical, social, economic, and systemic impact of these diseases for hundreds of millions of people. Our model is designed to mobilize resources to close the neglected tropical disease funding gap through partnerships with global philanthropists and private-sector investors. By pooling funds, the END Fund helps activist-philanthropists make outsized impacts with their investments. Through collaboration with our programmatic partners, we help deliver treatment at scale, accelerate innovations that improve the efficiency of drug delivery, provide program oversight to monitor quality and impact, and bring together partners, advocates, and investors. Because we direct resources and training activities through local partners, who know the landscape and can go where international agencies cannot or will not, we operate successfully and with measurable impact in some of the world's most challenging environments due to war or instability. Our focus has always been on large-scale change and we are committed to investing in and alongside local governments, building in-country technical tools and skills, and incorporating neglected tropical diseases into national health agendas for solid local ownership. In close partnership with stakeholders across the global neglected tropical disease community, the END Fund: Identified gaps and opportunities, by understanding investment needs and gaps in funding for neglected tropical diseases, landscapes investable opportunities, and increases coordination among stakeholders. The END Fund also builds coalitions, by mobilizing and activating collaboration among country-level stakeholders, including ministries of health, programmatic partners, investors, etc. The END Fund designs programs by working with ministries of health and programmatic partners to expand data collection, mapping, and sector knowledge in order to identify compelling program opportunities. The END Fund trains partners by aiming to grow and strengthen the pool of partner organizations to assist local governments in the implementation of quality neglected tropical disease programs. The END Fund manages grants and provides technical support by conducting country program visits and provides partner support, technical assistance, and training as needed. In 2024, the END Fund supported the distribution of 247,323,479 NTD treatments with 152,630,533 people treated across 21 countries by 27 implementing partners. During the same period, 38,100 surgeries were conducted in 12 countries by 15 implementing partners and 1,198,935 health care workers trained across 24 countries by 31 implementing partners. 66987920 true true false false false false false true false false true false false true true true true false false false true true false false false false false true false true false false false false false false false false false false false false false false false false false false false false true 36 0 true 44 true false false false false false false false false false false false false X 6 6 false false false false false false false true false false false false true true true true true true true true false false CA FL GA AL HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA AR WV WI X X HANNAH CHANG 6466909775 2 PARK AVENUE 28TH FLOOR NEW YORK NY 10016 ALAN MCCORMICK VICE CHAIR 1.0 X X 0 0 0 SCOTT POWELL TREASURER (thru December 1, 2024) 1.0 X X 0 0 0 Tsitsi Masiyiwa CHAIR 1.0 X X 0 0 0 CHRISTINE WACHTER CAMPBELL DIRECTOR 1.0 X 0 0 0 ENGLISH SALL DIRECTOR 1.0 X 0 0 0 MICHAEL HOFFMAN DIRECTOR 1.0 X 0 0 0 MOSES BOCKARIE DIRECTOR 1.0 X 0 0 0 DANIEL DALEY SR VP of Finance and Admin (thru June 15, 2024), Acting COO (as of June 15, 2024) 40.0 X 373799 0 3159 DIANA BENTON SCHECHTER COO / BOARD SECRETARY (thru June 15, 2024) INTERIM CEO (as of June 15, 2024) 40.0 X 394601 0 40825 ELLEN AGLER CEO thru June 15, 2024 40.0 X 284219 0 33017 CAROLINE KARUTU VP of Programs 40.0 X 259477 0 21027 ELLIE DEHGHAN Head of Legal & Global Operations 40.0 X 233865 0 33708 MIREILLE MATHER VP of Investor Relations 40.0 X 245865 0 60066 MODUPEOLA ODUSOTE Head of Culture & Talent 40.0 X 227398 0 58495 SAMUEL MAYER VP of Global Strategic Partnerships 40.0 X 267765 0 16938 2286989 0 267235 28 false true false Atlas Technology Solutions Inc 1331 F Street NW Suite 420 Washington DC 20004 Global Employer of Record 6306751 Elevate Destinations 288 Norfolk Street Suite 4 Cambridge MA 02139 Travel, event meeting service 418619 Davycas International GOUNGHIN RUE 834 PETIT PARIS OUAGADOUGOU UV Consulting 338067 WI-HER LLC 8212 Old Courthouse Road Ste A Vienna VA 22182 Consulting 255548 Panorama Strategy 2101 Fourth Avenue Suite 2100 Seattle WA 981212359 CONSULTING 254700 15 61399678 61399678 0 0 0 0 0 934656 934656 0 0 20000 26000 0 -6000 -6000 -6000 0 Other Income 344548 344548 0 0 0 0 344548 62672882 0 0 1273204 10413483 10413483 40473967 40473967 1129619 499929 520834 108856 8806113 6729968 424788 1651357 249083 152221 28233 68629 1661337 1106904 204503 349930 1200000 894433 119120 186447 46224 30364 4170 11690 84376 84376 5845640 4007092 652688 1185860 285298 168102 160 117036 109344 63737 24617 20990 253806 74596 140462 38748 382128 252710 55452 73966 1706447 1196382 148319 361746 1403966 882769 91034 430163 7701 4527 1451 1723 88322 18328 62884 7110 Subscriptions 28801 18408 1765 8628 Fundraising Platform Fees 5902 5902 0 0 0 0 74181557 66987920 2564856 4628781 21352154 25896878 21040526 5379952 4351235 3689911 0 0 0 0 702989 581759 343244 329834 21111 13410 0 0 2935862 3367959 50403877 38929869 484863 914148 0 0 2200071 1871942 2684934 2786090 X 296764 -62395 47422179 36206174 47718943 36143779 50403877 38929869 X -11508675 -66489 X false true true false X 12003675 15492363 16646973 11864771 5656318 61664100 0 0 12003675 15492363 16646973 11864771 5656318 61664100 19997470 41666630 130880 10930 8159 728871 934656 1813496 0 0 0 0 0 344548 344548 63822144 0 0.65286 0.64308 X Schedule A, Part II, Line 1 Unusual Grants 2024 - $55,743,359 2023 - $43,715,751 2022 - $62,480,667 2021 - $19,530,950 2020 - $10,652,528 Schedule A, Part II, Line 10 Other Income DESCRIPTION - , COLUMN A - , COLUMN B - , COLUMN C - , COLUMN D - , COLUMN E - 344548.0, COLUMN F - 344548.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 130000 X X Donated artwork is for sale and to be used for the programmatic work of the END Fund. false 135610 135610 0 133199 121108 12091 74435 73116 1319 13410 Right of Use Asset 1750624 Receivable - Due from UK 1487335 Artwork 130000 3367959 Federal Income Taxes Lease Liability 1871942 1871942 X 62672882 0 0 62672882 0 0 62672882 74248046 66489 0 66489 74181557 0 0 74181557 Schedule D, Part III, Line 4 Collections of art - description of collections 5 photographs of artwork which is artistic and photojournalistic, highlighting the consequences of NTDs and stories of the people suffering from them. 1. At the Crossroad of Faith and Reason; This piece depicts the role of traditional religions in Africa plays a key role in formulating and transmitting cultures that bind a community. In this piece, the discourse is around the understanding of the role that traditional medicine plays as it relates to western medicines. As I read, the scientific community's understanding is that traditional beliefs must be reconciled with science in a way that the former is medicine for the spirit while the latter is medicine for the body. 2. The Barriers Within; In most cases of documenting stories relating to disease, many conditions are not only based on lack of access to medical treatment, but also on lack of information. The role of education in prevention and the role of NTDs in access to education creates a vicious cycle that also impacts economics. 3. The Knowledge of Sorrow; Important research done by scientists in Africa relating to NTDs is often not widely documented. The process of eradicating NTDs is not only a road relating to medical administration and engagement of governments, but also requires an understanding of causes and preventions. In this regard, the piece incorporates flies in a glass container as a reflection of the role of the fly. This was inspired by a researcher explaining a technique to capture files for further analysis in the laboratory. Hence, the science of disease is an integral part of finding solutions towards a healthy society. 4. The Valley of my Shadow; Created to address the stigma associated with patients of NTD's. The piece echoes fear, loneliness, and isolation. Even in cases of full recovery, the remnant of stigmatization still has an impact on the individual. In the context of Africa, some choose to live away from their communities or hide away from public reaction to their ailments. All of which also leads to psychological impact, resulting in depression, insecurity, anxiety, and other mental conditions. Hence, human suffering is not only in the physical, but also in our hearts. 5. Trail of the Reaping Light; Through research and reading first encounters regarding patients with NTDs, I came across a story of a woman who became blind from disease and needed her daughter's support to live with the new realities of her lost vision. In the story, the daughter would leave her mother a long rope that led outside to the toilet. Therefore, the piece depicts the sense of helplessness and the fear that must encroach of learning to see with sound. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote Accounting principles generally accepted in the United States of America prescribe requirements for the recognition of income taxes in the financial statements, and the amounts recognized are affected by income tax positions taken by the Organization in its tax returns. The END Fund, Inc. (U.S.) is exempt from Federal income taxes under Section 501(c)(3) of the Internal Revenue Code. The Organization's status as an exempt organization is defined as an income tax position under these requirements. While management believes it has complied with the Internal Revenue Code, the sustainability of some income tax positions taken by the Organization in its tax returns may be uncertain. There are minimum thresholds of likelihood that uncertain tax positions are required to meet before being recognized in the financial statements. Management does not believe that the Organization Fund has any material uncertain tax positions at December 31, 2024 and 2023. Accordingly, no provision or liability for income taxes has been recorded in the financial statements. In addition, the Organization has no income tax related penalties or interest for the periods reported in these financial statements. In the event that interest and penalties were due relating to an unsustainable tax position, they would be treated as a component of income tax expense. true South Asia 0 0 Grantmaking NTDS 405454 Sub-Saharan Africa 0 0 Grantmaking NTDS 40641894 Middle East and North Africa 0 0 Grantmaking NTDS 326618 0 0 0 0 0 0 41373966 0 41373966 Middle East and North Africa NTDs 326618 WIRE FMV South Asia NTDs 155454 WIRE FMV South Asia NTDs 250000 WIRE FMV Sub-Saharan Africa NTDs 360659 WIRE FMV Sub-Saharan Africa NTDs 182130 WIRE FMV Sub-Saharan Africa NTDs 122544 WIRE FMV Sub-Saharan Africa NTDs 442136 WIRE FMV Sub-Saharan Africa NTDs 4455134 WIRE FMV Sub-Saharan Africa NTDs 301394 WIRE FMV Sub-Saharan Africa NTDs 4989341 WIRE FMV Sub-Saharan Africa NTDs 295398 WIRE FMV Sub-Saharan Africa NTDs 240128 WIRE FMV Sub-Saharan Africa NTDs 3252025 WIRE FMV Sub-Saharan Africa NTDs 2820362 WIRE FMV Sub-Saharan Africa NTDs 774039 WIRE FMV Sub-Saharan Africa NTDs 341325 WIRE FMV Sub-Saharan Africa NTDs 292663 WIRE FMV Sub-Saharan Africa NTDs 2544586 WIRE FMV Sub-Saharan Africa NTDs 962926 WIRE FMV Sub-Saharan Africa NTDs 120000 WIRE FMV Sub-Saharan Africa NTDs 1359873 WIRE FMV Sub-Saharan Africa NTDs 785814 WIRE FMV Sub-Saharan Africa NTDs 206384 WIRE FMV Sub-Saharan Africa NTDs 1815224 WIRE FMV Sub-Saharan Africa NTDs 151346 WIRE FMV Sub-Saharan Africa NTDs 373749 WIRE FMV Sub-Saharan Africa NTDs 202721 WIRE FMV Sub-Saharan Africa NTDs 470472 WIRE FMV Sub-Saharan Africa NTDs 1648236 WIRE FMV Sub-Saharan Africa NTDs 10940 WIRE FMV Sub-Saharan Africa NTDs 570560 WIRE FMV Sub-Saharan Africa NTDs 120000 WIRE FMV Sub-Saharan Africa NTDs 1574424 WIRE FMV Sub-Saharan Africa NTDs 506160 WIRE FMV Sub-Saharan Africa NTDs 750000 WIRE FMV Sub-Saharan Africa NTDs 167184 WIRE FMV Sub-Saharan Africa NTDs 84130 WIRE FMV Sub-Saharan Africa NTDs 1018558 WIRE FMV Sub-Saharan Africa NTDs 757629 WIRE FMV Sub-Saharan Africa NTDs 2426912 WIRE FMV Sub-Saharan Africa NTDs 537556 WIRE FMV Sub-Saharan Africa NTDs 123029 WIRE FMV Sub-Saharan Africa NTDs 234734 WIRE FMV Sub-Saharan Africa NTDs 1795969 WIRE FMV Sub-Saharan Africa NTDs 453498 WIRE FMV 43 2 false false false false false true Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds THE END FUND HAS A ROBUST GRANT AND PROJECT MANAGEMENT PROCESS SINCE THIS IS THE PRIMARY PROGRAMMATIC WORK THE ORGANIZATION UNDERTAKES. GRANT MANAGEMENT INCLUDES IN-PERSON MEETINGS WITH GRANT RECIPIENTS, DUE DILIGENCE ON THEIR PROJECT, DOCUMENTATION ENCAPSULATED IN A COMPREHENSIVE GRANT AGREEMENT, REGULAR REPORTING INCLUDING CURRENT RESOURCE ANALYSIS AND FUTURE GRANT REQUESTS. UPON COMPLETION OF A PROJECT THE ORGANIZATION UNDERTAKES A CRITICAL REVIEW OF THE GRANT TO GLEAN LESSONS LEARNED FOR USE IN FUTURE PROJECTS. DOCUMENTATION USED IN GRANTMAKING INCLUDE AN APPLICATION FORM WITH A PERFORMANCE ASSESSMENT FRAMEWORK, A PROPOSED BUDGET AND CASH FLOW FROM THE GRANTEE, RISK SCORING, THE PREVIOUSLY MENTIONED GRANT AGREEMENT, REPORTING TEMPLATES FOR FINANCIAL AND NARRATIVE SECTIONS, AND WRITTEN REPORTS FOLLOWING FIELD VISITS AND INSPECTIONS. THE ORGANIZATION PROGRAM STAFF MEETS IN PERSON WITH THE GRANT RECIPIENT'S TEAM AND DISCUSSES PLANNED OUTCOMES, WORK DETAILS, PROCESSES AND REPORTING. ALL WRITTEN GRANTMAKING MATERIALS ARE RETAINED CENTRALLY FOR ARCHIVAL PURPOSES. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements MIDDLE EAST AND NORTH AFRICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements MIDDLE EAST AND NORTH AFRICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual true Akros Inc 4302 Timberlane Missoula MT 59802 263668995 138695 FMV NTDS Helen Keller International One Dag Hammarskjold Plaza Floor 2 New York NY 10017 135562162 501(c)(3) 885410 FMV NTDS IMA WORLD HEALTH 1730 M STREET NW SUITE 1100 WASHINGTON DC 20036 522112460 501(c)(3) 787500 FMV NTDS Orbis International 52 Vanderbilt Avenue 8th Floor New York NY 10017 237297651 501(c)(3) 2182879 FMV NTDS The Carter Center Inc One Copenhill 453 John Lewis Freedom Parkway NE Atlanta GA 30307 581454716 501(c)(3) 3173117 FMV NTDS United Front Against Riverblindness PO Box 218 Princeton Junction NJ 08550 364551151 501(c)(3) 2345882 FMV NTDS 5 1 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. THE END FUND HAS A ROBUST GRANT AND PROJECT MANAGEMENT PROCESS SINCE THIS IS THE PRIMARY PROGRAMMATIC WORK THE ORGANIZATION UNDERTAKES. GRANT MANAGEMENT INCLUDES IN-PERSON MEETINGS WITH GRANT RECIPIENTS, DUE DILIGENCE ON THEIR PROJECT, DOCUMENTATION ENCAPSULATED IN A COMPREHENSIVE GRANT AGREEMENT, REGULAR REPORTING INCLUDING CURRENT RESOURCE ANALYSIS AND FUTURE GRANT REQUESTS. UPON COMPLETION OF A PROJECT THE ORGANIZATION UNDERTAKES A CRITICAL REVIEW OF THE GRANT TO GLEAN LESSONS LEARNED FOR USE IN FUTURE PROJECTS. DOCUMENTATION USED IN GRANTMAKING INCLUDE AN APPLICATION FORM WITH A PERFORMANCE ASSESSMENT FRAMEWORK, A PROPOSED BUDGET AND CASH FLOW FROM THE GRANTEE, RISK SCORING, THE PREVIOUSLY MENTIONED GRANT AGREEMENT, REPORTING TEMPLATES FOR FINANCIAL AND NARRATIVE SECTIONS, AND WRITTEN REPORTS FOLLOWING FIELD VISITS AND INSPECTIONS. THE ORGANIZATION PROGRAM STAFF MEETINGS IN PERSON WITH THE GRANT RECIPIENT'S TEAM AND DISCUSSES PLANNED OUTCOMES, WORK DETAILS, PROCESSES AND REPORTING. ALL WRITTEN GRANTMAKING MATERIALS ARE RETAINED CENTRALLY FOR ARCHIVAL PURPOSES. X X X X X false false false false false false false false false DIANA BENTON SCHECHTER COO / BOARD SECRETARY (thru June 15, 2024) INTERIM CEO (as of June 15, 2024) 394601 0 0 0 0 0 19669 0 21156 0 435426 0 0 0 ELLEN AGLER CEO thru June 15, 2024 182159 0 102060 0 0 0 9356 0 23661 0 317236 0 0 0 DANIEL DALEY SR VP of Finance and Admin (thru June 15, 2024), Acting COO (as of June 15, 2024) 373799 0 0 0 0 0 0 0 3159 0 376958 0 0 0 CAROLINE KARUTU VP of Programs 259477 0 0 0 0 0 12800 0 8227 0 280504 0 0 0 SAMUEL MAYER VP of Global Strategic Partnerships 267765 0 0 0 0 0 0 0 16938 0 284703 0 0 0 MIREILLE MATHER VP of Investor Relations 245865 0 0 0 0 0 12617 0 47449 0 305931 0 0 0 MODUPEOLA ODUSOTE Head of Culture & Talent 227398 0 0 0 0 0 11750 0 46745 0 285893 0 0 0 ELLIE DEHGHAN Head of Legal & Global Operations 233865 0 0 0 0 0 11652 0 22056 0 267573 0 0 0 Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing body There is no such committee with authority to act on behalf of the governing body. Therefore this question has been checked no. Form 990, Part VI, Line 11b Review of form 990 by governing body THE FORM 990 IS PREPARED BY MANAGEMENT IN CONJUNCTION WITH THE EXTERNAL TAX PREPARERS OF THE ORGANIZATION. WHEN SUBSTANTIALLY COMPLETE IT IS SENT ELECTRONICALLY TO THE BOARD OF DIRECTORS FOR A REVIEW AND IS PRESENTED AT THE BOARD MEETING BEFORE IT IS FINALIZED AND FILED WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy THE ORGANIZATION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY THAT INCLUDES A DEFINITION OF WHAT CONFLICT OF INTEREST MEANS, PROCESSES TO NOTIFY RELEVANT PARTIES, PROCEDURES TO RECUSE CONFLICTED INDIVIDUALS, AND ACTION NEEDED TO DOCUMENT THE STEPS THAT WERE TAKEN. EACH BOARD MEMBER IS REQUIRED TO COMPLETE AN ANNUAL CONFLICT OF INTEREST STATEMENT. THE SIGNED STATEMENTS ARE REVIEWED AND RETAINED BY MANAGEMENT. ALL STAFF AND OFFICERS ARE PROVIDED A COPY OF THE CONFLICT OF INTEREST POLICY. ALL STAFF AND OFFICERS ARE REQUIRED TO DISCLOSE ANY DIRECT OR INDIRECT FINANCIAL OR OTHER MATERIAL INTEREST WITH ANY PROPOSED OR EXISTING ARRANGEMENT WITH THE ORGANIZATION PRIOR TO THE START OF ANY NEGOTIATION WITH RESPECT TO SUCH MATTER. IN ACCORDANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, ANY ACTUAL OR PERCEIVED CONFLICTS OF INTEREST IDENTIFIED ARE ADDRESSED BY THE BOARD TO DETERMINE IF CORRECTIVE OR RESTRICTIVE ACTION, INTENDED TO PROTECT THE ORGANIZATION'S INTEREST, IS NEEDED. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE END FUND HAS A POLICY IN PLACE TO EVALUATE THE PERFORMANCE AND THE COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. THE BOARD CONSIDERS SIMILAR NONPROFIT ORGANIZATIONS IN BENCHMARKING AGAINST A PEER GROUP, LOOKS AT PERFORMANCE OF THE CEO, AND RECOMMENDS A SALARY AND POSSIBLY A BONUS AMOUNT FOR THE PERIOD UNDER REVIEW. THE ORGANIZATION ENGAGES AN EXTERNAL COMPENSATION CONSULTANT TO CONDUCT EXTENSIVE BENCHMARKING RESEARCH AND PROVIDE COMPARABILITY DATA. A DIALOGUE IS FACILITATED WITH THE CEO AT EACH STAGE OF THE REVIEW PROCESS. ANY ADJUSTMENTS TO COMPENSATION ARE APPROVED BY THE FULL BOARD. THE CEO IS NOT PRESENT DURING THIS STAGE OF THE BOARD DELIBERATIONS AND APPROVALS. THE DELIBERATIONS AND DECISIONS REGARDING THE REVIEW AND APPROVAL OF THE CEO'S COMPENSATION ARE DOCUMENTED IN THE MINUTES TO BOARD OF DIRECTORS MEETING. THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE CEO'S COMPENSATION ON AN ANNUAL BASIS. THIS PROCESS WAS LAST DONE IN 2024. Form 990, Part VI, Line 15b Process to establish compensation of other employees THE COMPENSATION FOR THE COO IS REVIEWED AND APPROVED BY THE ORGANIZATION'S BOARD OF DIRECTORS. IN DETERMINING COMPENSATION, THE ORGANIZATION ENGAGES AN EXTERNAL COMPENSATION CONSULTANT TO CONDUCT EXTENSIVE BENCHMARKING RESEARCH AND PROVIDE COMPARABILITY DATA. THE DELIBERATIONS REGARDING THE DETERMINATION OF COMPENSATION TOOK PLACE DURING THE EXECUTIVE SESSION AND THE DECISION WITH REGARDS TO COMPENSATION WAS DOCUMENTED. THE PROCESS FOR DETERMINING COMPENSATION IS PERFORMED ON AN ANNUAL BASIS. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION POSTS ITS AUDITED FINANCIAL STATEMENTS AND THE PUBLIC DISCLOSURE COPY OF THE FORM 990 ON ITS WEBSITE AT WWW.END.ORG. THE FORM 990 IS ALSO AVAILABLE AT WWW.GUIDESTAR.COM. GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND THE FORM 1023 IS AVAILABLE TO THE PUBLIC UPON REQUEST, SUBMITTED BY MAIL, TELEPHONE OR EMAIL. Form 990, Part XI, Line 9 Other changes in net assets or fund balances Foreign Exchange Gain/(Loss) - -66489;